Allspring Global Investments’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,149
Closed -$16.2K 1709
2025
Q2
$16.2K Hold
11,149
﹤0.01% 1603
2025
Q1
$16K Sell
11,149
-6,802
-38% -$10.7K ﹤0.01% 1713
2024
Q4
$19.4K Hold
17,951
﹤0.01% 1725
2024
Q3
$17K Buy
+17,951
New +$22.6K ﹤0.01% 2029
2023
Q4
Sell
-13,321
Closed -$18.9K 2612
2023
Q3
$18.9K Sell
13,321
-38,951
-75% -$55.2K ﹤0.01% 2520
2023
Q2
$60.1K Buy
52,272
+47,888
+1,092% +$56.5K ﹤0.01% 2241
2023
Q1
$4.65K Buy
4,384
+328
+8% +$473 ﹤0.01% 2652
2022
Q4
$6.17K Sell
4,056
-89
-2% -$153 ﹤0.01% 2768
2022
Q3
$8K Sell
4,145
-14,861
-78% -$31.3K ﹤0.01% 2750
2022
Q2
$25K Sell
19,006
-36,147
-66% -$53.6K ﹤0.01% 2434
2022
Q1
$116K Buy
55,153
+5,372
+11% +$13.1K ﹤0.01% 2721
2021
Q4
$184K Buy
+49,781
New +$214K ﹤0.01% 2649

Other funds holding PGEN

Allspring Global Investments's PGEN Position: Q3 2025 in Review

Allspring Global Investments sold out of Precigen (PGEN) in Q3 2025, closing a stake of 11,149 shares — an estimated $16.2K sold.

Allspring Global Investments first reported a position in PGEN in Q4 2021 and held it in 12 quarters. The position peaked at $184K in Q4 2021. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Allspring Global Investments reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Allspring Global Investments sold 11,149 Precigen shares in Q3 2025, an estimated $16.2K.
  • Allspring Global Investments first reported a position in Precigen in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Precigen position peaked at $184K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Allspring Global Investments's 13F filing for Q3 2025, filed 20 Oct 2025.